Joan P. Zape
Jazz Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Synthesis of Tetrazole Derivatives, Zebrafish Biomedical Research Applications, Synthesis and Characterization of Heterocyclic Compounds, Chronic Myeloid Leukemia Treatments, Immune cells in cancer
Most-Cited Works
- → Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration(2011)431 cited
- → Repression of arterial genes in hemogenic endothelium is sufficient for haematopoietic fate acquisition(2015)135 cited
- → Hemogenic endothelium: Origins, regulation, and implications for vascular biology(2011)46 cited
- → The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β–Dependent Pathway(2011)28 cited
- → Cell cycle dynamics and complement expression distinguishes mature haematopoietic subsets arising from hemogenic endothelium(2017)23 cited
- → Phenotypic fidelity (or not?) of epithelial cells in the liver(2012)14 cited
- → Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming(2017)14 cited
- → Let-7 microRNA-dependent control of leukotriene signaling regulates the transition of hematopoietic niche in mice(2017)13 cited
- → Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis and Suppresses Proliferation of Ba/F3 FLT-3 ITD Mutant Cells in Vitro and in Vivo through Inhibition of FLT3 and AKT.(2008)2 cited
- → Supplementary Figure 3 from The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β–Dependent Pathway(2023)